5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
本週有關生物技術的5支股票的重要催化劑：默沙東、Intellia、Verona等等。
Biotech stocks are high-risk, high-return opportunities that are under the mercy of several make-or-break catalysts, most of which are binary events. It pays to remain cognizant of the timing of these catalysts and which way they will likely pan out.
生物科技股是高風險、高回報的機會，受多種成敗催化劑的擺佈，其中大多數是二元事件。了解這些催化劑的時機以及它們可能以何種方式發揮作用是值得的。
Benzinga brings to investors a weekly feature focusing on five key catalysts that could impact the stock prices of the respective companies in an appreciable manner.
Benzinga每週爲投資者帶來專題報道，重點關注五種關鍵催化劑，這些催化劑可能會對各自公司的股價產生明顯影響。
1. Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
1。Arrowhead Pharmicals, Inc.（納斯達克股票代碼：ARWR）
Date: Tuesday, June 25
Catalyst: Discussion of Phase 3 PALISADE study of investigational plozasiran in patients with genetically confirmed or clinically diagnosed familial chylomicronemia syndrome
日期：6月25日星期二
催化劑：討論針對經基因確認或臨床診斷的家族性乳糜微粒血癥綜合徵患者的在研plozasiran的3期PALISADE研究
On June...
6月...
登入免費觀看全文
登入/註冊